CYP1A2 and urinary bladder carcinoma: Haplotype 3 (G/G): The third haplotype, defined by the G/G genotype of the SNP CYP1A2.3860.G.A, was found in 86 individuals (50.6%) in bladder cancer patients and 109 individuals (64.1%) in the control group in the codominant model.